EKF Diagnostics Holdings PLC
LSE:EKF

Watchlist Manager
EKF Diagnostics Holdings PLC Logo
EKF Diagnostics Holdings PLC
LSE:EKF
Watchlist
Price: 25.1 GBX -3.28% Market Closed
Market Cap: £109.3m

EKF Diagnostics Holdings PLC
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

EKF Diagnostics Holdings PLC
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
EKF Diagnostics Holdings PLC
LSE:EKF
Other
-£1.3m
CAGR 3-Years
N/A
CAGR 5-Years
-47%
CAGR 10-Years
1%
Smith & Nephew PLC
LSE:SN
Other
$1m
CAGR 3-Years
-31%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Other
-$338k
CAGR 3-Years
N/A
CAGR 5-Years
63%
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
Other
£100k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inspiration Healthcare Group PLC
LSE:IHC
Other
-£1m
CAGR 3-Years
-41%
CAGR 5-Years
3%
CAGR 10-Years
N/A
EMV Capital PLC
LSE:EMVC
Other
-£21k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
8%
No Stocks Found

EKF Diagnostics Holdings PLC
Glance View

Market Cap
109.3m GBX
Industry
Health Care

EKF Diagnostics Holdings Plc is a vitro diagnostics company, which designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2002-06-05. The firm's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. Its Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen, Quo-Lab A1c, UltraCrit, DiaSpect, HemataStat II and Creamatocrit Plus. The company operates in Germany, the United States, Russia and the United Kingdom.

EKF Intrinsic Value
24.77 GBX
Overvaluation 1%
Intrinsic Value
Price

See Also

What is EKF Diagnostics Holdings PLC's Other?
Other
-1.3m GBP

Based on the financial report for Jun 30, 2025, EKF Diagnostics Holdings PLC's Other amounts to -1.3m GBP.

What is EKF Diagnostics Holdings PLC's Other growth rate?
Other CAGR 10Y
1%

Over the last year, the Other growth was -268%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett